ckd-381
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 20, 2017 (NCT03211143)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04830930 | Phase 1 | Apr 21, 2021 | Chong Kun Dang Pharmaceutical, Seoul National University |
| NCT03558425 | Phase 1 | Jun 27, 2018 | Chong Kun Dang Pharmaceutical, Seoul National University |
| NCT03444402 | Phase 1 | Mar 2, 2018 | Chong Kun Dang Pharmaceutical, Seoul National University |
| NCT03211143 | Phase 1 | Jun 20, 2017 | Chong Kun Dang Pharmaceutical, Yonsei University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chong Kun Dang Pharmaceutical | For profit | 4 | 4 | 1 | 2017 |
| Seoul National University | Academic/Hospital | 3 | 0 | 1 | 2018 |
| Yonsei University | Academic/Hospital | 1 | 0 | 1 | 2017 |
3 organizations
Page 1 / 1